Cell Culture – News and Features

Researchers revealed that the rotavirus NSP4 protein drives disease severity by disrupting calcium signaling in infected and nearby cells. These disruptions worsen symptoms and trigger immune responses.

Two newly identified disease-causing genes, known as Bzw2 and Eif5a2, have been implicated in early prostate cancer development.

Researchers at Johns Hopkins and the Chinese Academy of Sciences discovered that a mouse protein, STELLA, blocks the cancer-associated protein UHRF1, reversing epigenetic changes that promote tumor growth.

A new type of off-the-shelf cell-based immunotherapy shows promise for B-cell lymphomas, and could make make future cellular immunotherapies less expensive and more accessible.

Technology Networks spoke with Dr. Thomas Dennison, University of Cambridge, to learn more about the advantages of using patient-derived organoids for modeling inflammatory bowel disease (IBD).

Researchers have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, autoimmune diseases and much more.

A new look at cancer cells: Würzburg researchers show how therapeutic antibodies work – thanks to an innovative method of super-resolution microscopy.

A new AI tool can accurately predict gene activity within any human cell, revealing the cell's inner mechanisms.

The injection of heart muscle spheroids derived from hiPSCs can aid heart attack recovery in animal models.

ECRC researchers developed a CRISPR-based gene therapy targeting dysferlin mutations in muscular dystrophy. By editing and transplanting corrected muscle stem cells, they restored protein function and regrew muscle in preclinical models.